Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06145763 · ClinicalTrials.gov registry record · NA

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

A NA study of Cigarette Smoking-Related Carcinoma, sponsored by Fred Hutchinson Cancer Center.

Recruiting
Registry status
NA
Development phase
776
Enrollment target
1
Study location

NCT06145763 is a NA study of Cigarette Smoking-Related Carcinoma that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 776 participants, above the 430-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (80% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06145763, a NA study of Cigarette Smoking-Related Carcinoma, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.

RECRUITING
Registry status
NA
Development phase
776 participants
Enrollment target
1
Study location

Study Summary

This clinical trial compares a new smoking cessation smartphone application (app) (IndigeQuit) to an existing smarphone app (National Cancer Institute \[NCI\] QuitGuide) for helping American Indians and Alaska Natives (AI/ANs) quit smoking. Compared to other racial/ethnic groups, AIANs have 6 times higher rates of developing smoking-related cancers, including lung cancer. Commercial cigarette smoking accounts for half of all deaths among AIANs nationwide. AIANs' often lack of access to smoking cessation interventions, which may be due to inequities in the healthcare system, lack of health insurance, living in rural areas, systemic racism, and historical trauma. There is also a lack of effective smoking cessation interventions for AIANs. Smartphone apps have the potential to deliver a low-cost smoking cessation intervention with wide reach to AIANs. Apps require no in-person delivery and no provider training, do not require integration into complex hospital systems, can be freely accessed on an app store, and are available at any time and any place. IndigeQuit is a behavioral intervention designed to help adults stop smoking by teaching skills for coping with smoking urges, staying motivated, and preventing relapse. The IndigeQuit app intervention may be more effective than the currently available NCI QuitGuide app at helping AIANs quit smoking.

Interventions

  • PROCEDURE Biospecimen Collection
  • BEHAVIORAL Smoking Cessation Intervention
  • OTHER Survey Administration

Study Locations (1)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 776 participants
Start Date 2025-07-03
Est. Completion 2028-11-30
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT06145763

The ClinicalTrials.gov registry entry for NCT06145763 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 776 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 430-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (80% higher). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT06145763 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06145763 about?

NCT06145763 is a clinical study titled "A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial". This clinical trial compares a new smoking cessation smartphone application (app) (IndigeQuit) to an existing smarphone app (National Cancer Institute \[NCI\] QuitGuide) for helping American Indians and Alaska Natives (AI/ANs) quit smoking. Compared to other racial/ethnic groups, AIANs have 6 times ...

What is the current status of trial NCT06145763?

This trial is currently recruiting. It is a NA study. The enrollment target is 776 participants. The study started on 2025-07-03. Estimated completion is 2028-11-30.

What conditions does trial NCT06145763 study?

This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.

What interventions are being tested in trial NCT06145763?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Smoking Cessation Intervention (BEHAVIORAL), Survey Administration (OTHER).

Who is sponsoring clinical trial NCT06145763?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06145763 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cigarette Smoking-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.